119 related articles for article (PubMed ID: 30899428)
1. Correction: Early assessment of tumor response to photodynamic therapy using combined diffuse optical and diffuse correlation spectroscopy to predict treatment outcome.
Thong PSP; Lee K; Toh HJ; Dong J; Tee CS; Low KP; Chang PH; Bhuvaneswari R; Tan NC; Soo KC
Oncotarget; 2019 Feb; 10(16):1602. PubMed ID: 30899428
[TBL] [Abstract][Full Text] [Related]
2. Early assessment of tumor response to photodynamic therapy using combined diffuse optical and diffuse correlation spectroscopy to predict treatment outcome.
Thong PSP; Lee K; Toh HJ; Dong J; Tee CS; Low KP; Chang PH; Bhuvaneswari R; Tan NC; Soo KC
Oncotarget; 2017 Mar; 8(12):19902-19913. PubMed ID: 28423634
[TBL] [Abstract][Full Text] [Related]
3. Correction: A tissue factor-cascade-targeted strategy to tumor vasculature: a combination of EGFP-EGF1 conjugation nanoparticles with photodynamic therapy.
Shi W; Yin Y; Wang Y; Zhang B; Tan P; Jiang T; Mei H; Deng J; Wang H; Guo T; Pang Z; Hu Y
Oncotarget; 2018 Apr; 9(25):17979. PubMed ID: 29707163
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic monitoring of Chlorin e6-mediated photodynamic therapy using diffuse optical measurements.
Dong J; Toh HJ; Thong PS; Tee CS; Bi R; Soo KC; Lee K
J Photochem Photobiol B; 2014 Nov; 140():163-72. PubMed ID: 25146878
[TBL] [Abstract][Full Text] [Related]
5. Correction: Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed.
Zhang N; Kong L; Shi F; Jing W; Wang H; Yang M; Yu J; Zhu H
Oncotarget; 2017 Dec; 8(66):110732. PubMed ID: 29300397
[TBL] [Abstract][Full Text] [Related]
6. Correction: Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes.
Cedena MT; Rapado I; Santos-Lozano A; Ayala R; Onecha E; Abaigar M; Such E; Ramos F; Cervera J; Díez-Campelo M; Sanz G; Rivas JH; Lucía A; Martínez-López J
Oncotarget; 2018 Jul; 9(56):30936. PubMed ID: 30112119
[TBL] [Abstract][Full Text] [Related]
7. Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget.
Qiu YQ; Yang CW; Lee YZ; Yang RB; Lee CH; Hsu HY; Chang CC; Lee SJ
Oncotarget; 2019 Aug; 10(47):4919. PubMed ID: 31448057
[TBL] [Abstract][Full Text] [Related]
8. Time-Resolved Diffuse Optical Spectroscopy and Imaging Using Solid-State Detectors: Characteristics, Present Status, and Research Challenges.
Alayed M; Deen MJ
Sensors (Basel); 2017 Sep; 17(9):. PubMed ID: 28906462
[TBL] [Abstract][Full Text] [Related]
9. Correction: The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy.
Cui J; Yang L; Guo L; Shao Y; Tan D; Li N; Zhang H
Oncotarget; 2019 Feb; 10(15):1539. PubMed ID: 30863500
[TBL] [Abstract][Full Text] [Related]
10. Correction:
Holien T; Misund K; Olsen OE; Baranowska KA; Buene G; Børset M; Waage A; Sundan A
Oncotarget; 2018 Nov; 9(89):36048. PubMed ID: 30542518
[TBL] [Abstract][Full Text] [Related]
11. Correction: MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma.
Xiang ZL; Zhao XM; Zhang L; Yang P; Fan J; Tang ZY; Zeng ZC
Oncotarget; 2019 Oct; 10(59):6398-6399. PubMed ID: 31695850
[TBL] [Abstract][Full Text] [Related]
12. Correction: A novel highly potent trivalent TGF-β receptor trap inhibits early-stage tumorigenesis and tumor cell invasion in murine Pten-deficient prostate glands.
Qin T; Barron L; Xia L; Huang H; Villarreal MM; Zwaagstra J; Collins C; Yang J; Zwieb C; Kodali R; Hinck CS; Kim SK; Reddick RL; Shu C; O'Connor-McCourt MD; Hinck AP; Sun LZ
Oncotarget; 2017 Aug; 8(34):57905. PubMed ID: 28915722
[TBL] [Abstract][Full Text] [Related]
13. Correction: Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma.
Caroline R; Sofia G; Catherine P; Remi B; Pierre C; Olivier B; Laurent G; Valentin A; Claude C; Odile F
Oncotarget; 2019 Mar; 10(22):2236. PubMed ID: 31040915
[TBL] [Abstract][Full Text] [Related]
14. Correction: Se
Zhang HN; Feng WL; An CN; Li WG
Oncotarget; 2018 Nov; 9(92):36542. PubMed ID: 30559936
[TBL] [Abstract][Full Text] [Related]
15. Correction: Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma.
Zhou J; Li Y; Zhang Y; Liu G; Tan H; Hu Y; Xiao J; Shi H
Oncotarget; 2019 Feb; 10(11):1224. PubMed ID: 30838094
[TBL] [Abstract][Full Text] [Related]
16. Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma.
Alon M; Arafeh R; Lee JS; Madan S; Kalaora S; Nagler A; Abgarian T; Greenberg P; Ruppin E; Samuels Y
Oncotarget; 2019 Feb; 10(13):1344. PubMed ID: 30863494
[TBL] [Abstract][Full Text] [Related]
17. Correction: Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma.
Valentini D; Rao M; Meng Q; von Landenberg A; Bartek J; Sinclair G; Paraschoudi G; Jäger E; Harvey-Peredo I; Dodoo E; Maeurer M
Oncotarget; 2018 Dec; 9(95):36817. PubMed ID: 30613370
[TBL] [Abstract][Full Text] [Related]
18. Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer.
Adamo B; Ricciardi GRR; Ieni A; Franchina T; Fazzari C; Sanò MV; Angelico G; Caruso M; Tuccari G; Adamo V
Oncotarget; 2019 Jan; 10(8):917. PubMed ID: 30783520
[TBL] [Abstract][Full Text] [Related]
19. Correction: HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody
Booth L; Roberts JL; Poklepovic A; Avogadri-Connors F; Cutler RE; Lalani AS; Dent P
Oncotarget; 2019 Aug; 10(49):5120-5122. PubMed ID: 31489122
[TBL] [Abstract][Full Text] [Related]
20. Correction: MMTV-NeuT/ATTAC mice: a new model for studying the stromal tumor microenvironment.
Yuan H; Wang X; Lu J; Zhang Q; Brandina I; Alexandrov I; Glazer RI
Oncotarget; 2018 Dec; 9(102):37808. PubMed ID: 30701035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
